Multibase India Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Multibase India Ltd is ₹ 166.7 as of 18 Mar 15:30 . The P/E Ratio of Multibase India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Multibase India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Multibase India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Multibase India Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Multibase India Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Multibase India Ltd is 358 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,766 Cr

What are the key factors driving the stock performance of Multibase India Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Multibase India Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Multibase India Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 19, 2026, the Multibase India Ltd stock price is INR ₹283.8. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1182.85.

How do dividend payouts of Multibase India Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Multibase India Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.